This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burdon, J. Articles by Nana, A Search for Related Content PubMed PubMed Citation Articles by Burdon, J. Articles by Nana, A

Original Articles

Chronic lung diseases and the perception of breathlessness: a clinical perspective

Breathlessness is an extremely common symptom. Its genesis is incompletely understood but is known to be largely determined by many of the mechanical factors associated with the act of breathing. As with all subjective sensations various other factors including volition, behavioural style and other cortical and subcortical factors play a part in its genesis. The relief of breathlessness is primarily directed at the underlying disorder. In those conditions and situations where specific therapy has little to offer or little impact it is reasonable to consider ways of reducing the perception of breathlessness by pharmacological means. However, to date there is no convincing evidence that use of drugs in the pursuit of the relief of breathlessness has any specific effect in modifying the perception of this often distressing symptom. Any reduction in breathlessness achieved in this way can be adequately explained in terms of a reduction in ventilation and other indices of respiratory mechanics.

This article has been cited by other articles:

				I. Ben-Aharon, A. Gafter-Gvili, M. Paul, L. Leibovici, and S. M. Stemmer Interventions for Alleviating Cancer-Related Dyspnea: A Systematic Review J. Clin. Oncol., May 10, 2008; 26(14): 2396 - 2404. [Abstract] [Full Text] [PDF]

				A. P Abernethy, D. C Currow, P. Frith, B. S Fazekas, A. McHugh, and C. Bui Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ, September 6, 2003; 327(7414): 523 - 528. [Abstract] [Full Text] [PDF]

				C.P. van Schayck and N.H. Chavannes Detection of asthma and chronic obstructive pulmonary disease in primary care Eur. Respir. J., January 1, 2003; 21(39_suppl): 16S - 22s. [Abstract] [Full Text] [PDF]

				C P van Schayck, J M C Loozen, E Wagena, R P Akkermans, and G J Wesseling Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study BMJ, June 8, 2002; 324(7350): 1370 - 1370. [Abstract] [Full Text] [PDF]

				P. J. POOLE, A. G. VEALE, and P. N. BLACK The Effect of Sustained-Release Morphine on Breathlessness and Quality of Life in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1877 - 1880. [Abstract] [Full Text] [PDF]

				C. D Shee Palliation in chronic respiratory disease Palliative Medicine, January 1, 1995; 9(1): 3 - 12. [Abstract] [PDF]